Hugel Builds Direct US Sales Force for Letybo, Launches K-TOX Push
Hugel Aesthetics is deploying a direct US sales force for Letybo and a new K-TOX campaign, moving its botulinum toxin business to in-house commercial operations.
Topic
Hugel
Topic
Hugel
Hugel Backs Physician-Led Research to Raise K-Aesthetics Profile
Hugel is funding physician-led research to build the clinical evidence base behind Korean aesthetic medicine as it competes globa…
Hugel Sets 1 Trillion Won Sales Target Within Three Years
Hugel targets 1 trillion won in sales within three years, staking its growth plan on the Korean aesthetics maker's injectable por…
Hugel Names Taiwan a Key Growth Market for Letybo Aesthetic Push
Hugel is targeting Taiwan as a priority growth market for its botulinum toxin Letybo and its wider aesthetic portfolio, aiming to…